On March 12, FDA’s Office of Prescription Drug Promotion (“OPDP”) posted an untitled letter on its webpage alleging that Institut Biochimique SA’s (“IBSA”) Facebook page for the drug Tirosint® misbranded the drug. The untitled letter is particularly noteworthy for its focus on one statement on a firm’s Facebook page.
Continue Reading FDA Issues Untitled Letter Focused On Promotional Claims On Facebook
enforcement
FCC Proposes $200,000 Fine For Simulated EAS Codes
By Inside Global Tech on
Posted in Broadcasting & Cable
The FCC has proposed fining Turner Broadcasting System $200,000 for allegedly transmitting simulated Emergency Alert System (EAS) codes 14 times over a six day period in the absence of an actual emergency. Two viewers complained that an advertisement that aired on Turner’s Adult Swim Network (which shares channel airtime with the Cartoon Network) contained audio…
CPNI Certifications Due on March 1
By Inside Global Tech on
Posted in Telecommunications
As a reminder, telecommunications carriers must submit their annual certifications regarding customer proprietary network information (CPNI) by March 1. CPNI is private customer information concerning telecommunications. Telecommunications carriers and providers of interconnected Voice over Internet Protocol (VoIP) must certify annually to the FCC that they comply with their obligations to protect and limit disclosure of CPNI. …
Continue Reading CPNI Certifications Due on March 1
FCC Proposes to Fine Telecommunications Licensee for Unauthorized Transfers of Control
By Yaron Dori on
Posted in Telecommunications
Last week, the FCC issued a Notice of Apparent Liability (NAL) to StanaCard, LLC, a licensed provider of, among other things, prepaid international telecommunications services. StanaCard today markets its services under the brand name “Keku.” The NAL proposed to fine StanaCard $21,000 for (1) failing to notify the FCC of a pro forma change in…